Month: April 2021

Caviar, a popular luxury brand better known for putting real gold on Apple products, has turned its attention to Tesla and, more specifically, the Model S Plaid+. They have created the most expensive and stupidest Tesla vehicle yet. There are now quite a few companies working on modding and tuning Tesla vehicles. Unplugged Performance is
0 Comments
Verge Genomics is taking a novel approach to speed drug discovery for devastating neurodegenerative diseases such as Parkinson’s, Alzheimer’s and ALS. Rather than spending exhaustive time with animal testing, the San Francisco-based company goes straight to the source.  “To succeed in humans, you need to start with humans,” says CEO Alice Zhang, whose drug discovery
0 Comments
There’s a helpful concept we use to help understand what distance from a given star you might expect to find planets with liquid water on their surface – liquid water being essential for life as we know it. It’s called the habitable zone. Every star has a habitable zone, but where that zone lies is
0 Comments
by Allison Kubo Hutchison Approximately 20 million years ago, prehistoric horses grazed on the flat grasslands and the now extinct bear-dog dug burrows for their young throughout the lands we now call Oregon and Washington. But below the ground, there was an eruption brewing that would shape over 81,000 square miles (200,000 square kilometers) reaching
0 Comments
The E in ESG is getting another boost as the United States rejoins the climate change fight, and space promises to play a central role. A rising number of companies have already added ESG scorecards to their annual reports, detailing the progress they are making toward environmental, social and corporate governance goals. As the importance
0 Comments
A shipment of Oxford–AstraZeneca COVID-19 vaccines lands at Abidjan, Ivory Coast. The African Union wants most vaccines to be produced on the continent by 2040.Credit: Sia Kambou/AFP/Getty Africa plans a vaccine-manufacturing revolution Africa’s leaders are on a path to ramp up vaccine manufacturing and boost regulatory bodies for medicines. On 13 April, they pledged to
0 Comments